PDL BioPharma Inc (NASDAQ:PDLI)

2.90
Delayed Data
As of Apr 20
 0.00 / 0.00%
Today’s Change
2.01
Today|||52-Week Range
3.55
+5.84%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for PDL BioPharma Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +3.45% increase from the last price of 2.90.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in PDL BioPharma Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.11
Sales
$57.3M
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -30.00%
 
 
 
 
 
 
Growthannually -65.49%
 
 
 
 
 
 

Sales

Growthquarterly -15.77%
 
 
 
 
 
 
Growthannually -39.99%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.